Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025

-- Conference Call Scheduled for Monday, August 11, 2025, at 8:00 a.m. ET --

NEWTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2025 financial results on Monday, August 11, 2025. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Monday, August 11, 2025, to discuss the financial results and other company updates.

Read more at prnewswire.com